| scholarly article | Q13442814 |
| P50 | author | Jiqiu Wang | Q58220592 |
| Bo Li | Q86052052 | ||
| P2093 | author name string | Jian Yang | |
| Zhiguo Zhang | |||
| Yifei Zhang | |||
| Guang Ning | |||
| Dongsheng Cai | |||
| Zhijian Zhang | |||
| Lina Jin | |||
| Xiangjian Meng | |||
| Huizhi Zhang | |||
| Shuangshuang Yao | |||
| P2860 | cites work | ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs | Q24290776 |
| A simple method for the isolation and purification of total lipides from animal tissues | Q25939009 | ||
| Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH) | Q27007515 | ||
| Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease | Q27301440 | ||
| Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways | Q28365886 | ||
| Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
| SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver | Q29547646 | ||
| Design and validation of a histological scoring system for nonalcoholic fatty liver disease | Q29614930 | ||
| Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH) | Q33755566 | ||
| Dynamic changes in the localization of thermally unfolded nuclear proteins associated with chaperone-dependent protection | Q33946970 | ||
| Berberine reduces methylation of the MTTP promoter and alleviates fatty liver induced by a high-fat diet in rats. | Q34053063 | ||
| Nonalcoholic steatohepatitis: definition and pathology | Q34215155 | ||
| New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease | Q34398065 | ||
| CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis | Q34432561 | ||
| Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins | Q34552498 | ||
| Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity | Q34603754 | ||
| PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver | Q34667494 | ||
| Chemical chaperones: a pharmacological strategy for disorders of protein folding and trafficking | Q35001649 | ||
| Tissue distribution of berberine and its metabolites after oral administration in rats | Q35035856 | ||
| Pharmacologic ER stress induces non-alcoholic steatohepatitis in an animal model. | Q35907138 | ||
| Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist | Q35991437 | ||
| Association between catalase gene polymorphisms and risk of chronic hepatitis B, hepatitis B virus-related liver cirrhosis and hepatocellular carcinoma in Guangxi population: a case-control study | Q36009191 | ||
| Endoplasmic reticulum stress in liver disease | Q36031838 | ||
| Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice | Q36479005 | ||
| Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis | Q36545096 | ||
| Central melanin-concentrating hormone influences liver and adipose metabolism via specific hypothalamic nuclei and efferent autonomic/JNK1 pathways | Q36872285 | ||
| Endoplasmic reticulum stress induces fibrogenic activity in hepatic stellate cells through autophagy | Q36941185 | ||
| Endoplasmic reticulum stress markers are associated with obesity in nondiabetic subjects | Q36971939 | ||
| Antioxidants reduce endoplasmic reticulum stress and improve protein secretion | Q36985084 | ||
| Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease | Q37002532 | ||
| Ethanol metabolism and oxidative stress are required for unfolded protein response activation and steatosis in zebrafish with alcoholic liver disease | Q37137783 | ||
| GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice | Q37170811 | ||
| Kupffer cells in non-alcoholic fatty liver disease: the emerging view. | Q37222183 | ||
| c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice | Q37376335 | ||
| CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis | Q37384997 | ||
| Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. | Q37388544 | ||
| Flurbiprofen ameliorated obesity by attenuating leptin resistance induced by endoplasmic reticulum stress | Q37644382 | ||
| Nonalcoholic fatty liver disease: pathology and pathogenesis | Q37676210 | ||
| Current therapeutic strategies in non-alcoholic fatty liver disease. | Q37859419 | ||
| Endoplasmic reticulum stress in nonalcoholic fatty liver disease | Q38027194 | ||
| Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin | Q38338847 | ||
| Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states | Q40250572 | ||
| Berberine stimulates glucose transport through a mechanism distinct from insulin. | Q42831138 | ||
| Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats. | Q42969049 | ||
| Isolation and culture of adult mouse hepatocytes | Q43142214 | ||
| Intracellular signaling pathways involved in acetaldehyde-induced collagen and fibronectin gene expression in human hepatic stellate cells | Q43601184 | ||
| Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults | Q43628070 | ||
| In vivo hepatic endoplasmic reticulum stress in patients with chronic hepatitis C. | Q44332232 | ||
| Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease | Q44934521 | ||
| Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. | Q45124709 | ||
| Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine | Q46656835 | ||
| Phyllanthus urinaria ameliorates the severity of nutritional steatohepatitis both in vitro and in vivo | Q46834315 | ||
| NASH: a hidden and silent fibroser finally revealed? | Q53856506 | ||
| [Therapeutic effect of berberine on 60 patients with type II diabetes mellitus and experimental research] | Q68072355 | ||
| Thermostability of a nuclear-targeted luciferase expressed in mammalian cells. Destabilizing influence of the intranuclear microenvironment | Q70824174 | ||
| CCAAT/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis | Q80229577 | ||
| Berberine activates thermogenesis in white and brown adipose tissue | Q86052055 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endoplasmic reticulum | Q79927 |
| steatohepatitis | Q2335423 | ||
| steatosis | Q1365091 | ||
| P304 | page(s) | 20848 | |
| P577 | publication date | 2016-02-09 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress | |
| P478 | volume | 6 |
| Q50931849 | Attenuation of hepatic steatosis by purple sweet potato colour is associated with blocking Src/ERK/C/EBPβ signalling in high-fat-diet-treated mice. |
| Q55397623 | Berberine Attenuates Macrophages Infiltration in Intracranial Aneurysms Potentially Through FAK/Grp78/UPR Axis. |
| Q90478758 | Berberine Inhibits Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome Activation and Pyroptosis in Nonalcoholic Steatohepatitis via the ROS/TXNIP Axis |
| Q52661291 | Berberine Protects Against Palmitate-Induced Apoptosis in Tubular Epithelial Cells by Promoting Fatty Acid Oxidation. |
| Q90698640 | Berberine ameliorates blockade of autophagic flux in the liver by regulating cholesterol metabolism and inhibiting COX2-prostaglandin synthesis |
| Q36292252 | Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease |
| Q94479681 | Berberine inhibits free fatty acid and LPS-induced inflammation via modulating ER stress response in macrophages and hepatocytes |
| Q37744848 | Berberine-sonodynamic therapy induces autophagy and lipid unloading in macrophage |
| Q41573474 | Comprehensive Study of Multiple Stages Progressing to Nonalcoholic Steatohepatitis with Subsequent Fibrosis in SD Rats |
| Q64064784 | Coptidis Rhizoma: a comprehensive review of its traditional uses, botany, phytochemistry, pharmacology and toxicology |
| Q37554361 | Cytochrome P450-2E1 promotes fast food-mediated hepatic fibrosis |
| Q30234449 | Dietary Factors Promoting Brown and Beige Fat Development and Thermogenesis |
| Q97522970 | Endoplasmic reticulum stress and liver diseases |
| Q93016049 | Herbal drug discovery for the treatment of nonalcoholic fatty liver disease |
| Q39077570 | Insights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver Diseases. |
| Q90602682 | Liver ASK1 protects from non-alcoholic fatty liver disease and fibrosis |
| Q98460000 | Modulation of gut microbiota mediates berberine-induced expansion of immuno-suppressive cells to against alcoholic liver disease |
| Q28067054 | Rhizoma Coptidis: A Potential Cardiovascular Protective Agent |
| Q28067321 | Role of berberine in Alzheimer's disease |
| Q28078754 | The Potential Mechanisms of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease |
Search more.